EXTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for EXTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for EXTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack on tough bile duct cancer
Disease control Recruiting nowThis study is testing whether combining two treatments works better for advanced bile duct cancer that cannot be removed by surgery. Doctors will use a small device to heat and destroy tumor cells inside the bile duct, followed by an immunotherapy drug (durvalumab) plus standard …
Matched conditions: EXTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Heat zaps tumors in bid to extend lives of bile duct cancer patients
Disease control Recruiting nowThis international trial is testing if a procedure that uses heat to destroy tumor tissue inside the bile duct can help people with advanced bile duct cancer live longer. All participants receive a standard three-drug treatment. Half will also get the heat treatment (called endob…
Matched conditions: EXTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Aichi Medical University • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New blood test aims to spot deadly bile duct cancer earlier
Diagnosis Recruiting nowThis study is testing a new blood test designed to improve the detection and management of bile duct cancers, which are often diagnosed late and have poor survival rates. The test looks for specific chemical markers released by cancer cells into the bloodstream. Researchers will …
Matched conditions: EXTRAHEPATIC CHOLANGIOCARCINOMA
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC